Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.

Arch Pathol Lab Med

From the Department of Pathology & Laboratory Medicine (Castañeda-Mogollón, Doolan, Toppings, Amarasekara, Tran, Pillai), University of Calgary, Calgary, Alberta, Canada.

Published: July 2023

AI Article Synopsis

  • Clostridioides difficile infection (CDI) causes significant diarrhea and is commonly treated with antibiotics, although these often fail or recur; understanding the microbiome in CDI patients is crucial.
  • This study examined stool samples from 358 patients (180 CDI-negative and 178 CDI-positive) to analyze how clinical factors relate to their gut bacteria profiles.
  • Findings revealed that the severity of CDI affected the microbiome, with significant differences in bacterial diversity linked to higher white blood cell counts and creatinine levels in infected patients.

Article Abstract

Context.—: Clostridioides difficile infection (CDI) is the world-leading cause of infectious nosocomial diarrhea and pseudomembranous colitis. Antibiotics are the first line of treatment against CDI despite the high likelihood of antibiotic failure and/or recurrence. More data are needed to correlate clinical variables with 16S rRNA microbiome profiles in CDI-infected patients.

Objective.—: To determine the relationship(s) between a patient's clinical factors and the stool bacteriome of CDI-positive patients and CDI-negative patients with diarrheal symptoms.

Design.—: This study used stool samples and clinical data from 358 patients with nosocomial diarrhea, who were divided by their CDI diagnosis (CDI-negative: n = 180; CDI-positive; n = 178). The stool bacteriome was profiled by amplicon deep sequencing of the 16S rRNA gene, followed by correlating clinical data.

Results.—: The stool bacteriome was significantly different by severity assessment regardless of CDI status. Phyla and species varied significantly by CDI diagnosis. Severity, defined as a serum white blood cell count greater than 15 cells/μL and/or a creatinine level greater than 1.5 mg/dL, correlated significantly with dysbiosis of the stool bacteriome profile of CDI-positive patients compared to CDI-negative patients. Serum white blood cell count was significantly higher in patients with bacterial dysbiosis, and high levels of creatinine were associated with low bacteriome diversity.

Conclusions.—: Clinical severity of CDI influences the stool microbiome of infected patients. To date, this study has the largest data set comparing 16S rRNA microbiome profiles and clinical variables between CDI-infected and noninfected individuals.

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2021-0636-OADOI Listing

Publication Analysis

Top Keywords

stool bacteriome
16
16s rrna
12
clinical severity
8
stool microbiome
8
clostridioides difficile
8
difficile infection
8
nosocomial diarrhea
8
clinical variables
8
rrna microbiome
8
microbiome profiles
8

Similar Publications

Background: Infants exposed to HIV but uninfected have altered immune profiles which include heightened systemic inflammation. The mechanism(s) underlying this phenomenon is unknown. Here, we investigated differences in neonatal gut bacterial and viral microbiome and associations with inflammatory biomarkers in plasma.

View Article and Find Full Text PDF

Impact of gestational diabetes mellitus in gut and human breast milk microbiome in Colombian women and their infants.

Rev Argent Microbiol

December 2024

Unidad Académica Multidisciplinaria Reynosa Aztlán - Universidad Autónoma de Tamaulipas, Reynosa, Mexico. Electronic address:

Human breast milk (HBM) is a vital source of macronutrients and micronutrients that are crucial for an infant's development. Recent studies have shown that HBM contains diverse microorganisms, including bacteria, viruses, protozoa, and anaerobic fungi. Additionally, novel research has revealed that individuals with metabolic disorders, such as diabetes mellitus, are prone to dysbiosis in their gut microbiome.

View Article and Find Full Text PDF

Background: Pepper from species is a well-established spice with a rich history of culinary use. Some observations have linked its consumption to gastrointestinal discomfort and alterations in stool patterns while it is considered beneficial in some cultures. However, there is lack of information on the direct effect of pepper consumption on human gut microbiota, we conducted dietary intervention studies to assess the impact of pepper on gut bacteriome composition in humans.

View Article and Find Full Text PDF
Article Synopsis
  • Autism spectrum disorder (ASD) currently has no effective diagnostic or treatment methods, but disruptions in gut microbiota have been linked to ASD, leading to research into probiotics and dietary changes as potential therapies.
  • A study compared the gut microbiomes of children with ASD to typically developing children, identifying unique dysbiosis patterns and assessing the impact of a combined probiotic (Probio-M8) and medium-carbohydrate diet over three months.
  • Results indicated that the intervention significantly improved autism symptoms and gastrointestinal health, with corresponding positive changes in gut bacteria and associated metabolites, suggesting that this approach could be a valuable addition to ASD treatment options.
View Article and Find Full Text PDF

The integrative multi-kingdom interaction of the gut microbiome in ulcerative colitis (UC) and Crohn's disease (CD) remains underinvestigated. Here, we perform shotgun metagenomic sequencing of feces from patients with UC and CD, and healthy controls in the Japanese 4D cohort, profiling bacterial taxa, gene functions, and antibacterial genes, bacteriophages, and fungi. External metagenomic datasets from the US, Spain, the Netherlands, and China were analyzed to validate our multi-biome findings.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!